1. Zhu Y, Parada LF . The molecular and genetic basis of neurological tumours. Nat Rev Cancer 2002; 2: 616–626.
2. Sonoda Y, Ozawa T, Hirose Y, Aldape KD, McMahon M, Berger MS et al. Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma. Cancer Res 2001; 61: 4956–4960.
3. Sonoda Y, Ozawa T, Aldape KD, Deen DF, Berger MS, Pieper RO . Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma. Cancer Res 2001; 61: 6674–6678.
4. Chin L, Artandi SE, Shen Q, Tam A, Lee SL, Gottlieb GJ et al. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 1999; 97: 527–538.
5. Peraud A, Kreth FW, Wiestler OD, Kleihues P, Reulen HJ . Prognostic impact of TP53 mutations and P53 protein overexpression in supratentorial WHO grade II astrocytomas and oligoastrocytomas. Clin Cancer Res 2002; 8: 1117–1124.